Longer Hospital Stays, Greater Risk of COVID-19 Death in Men

Priscilla Lynch

October 08, 2020

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

New research presented at the 2020 ESCMID Conference on Coronavirus Disease (ECCVID) show that men with COVID-19 have worse outcomes than women, possibly related to them experiencing higher levels of inflammation.

The study by Frank Hanses, MD, University Hospital Regensburg, Germany, and colleagues, shows that men have a 62% increased risk of COVID-19-associated death compared with women, after adjustment for various factors.

Increasing evidence suggests a sex difference in SARS-CoV-2 infections. In this study, the authors present a first analysis of the international multicenter Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS) dataset on the impact of sex in COVID-19. They retrospectively assessed 3,129 adult patients with COVID-19, enrolled between March and July 2020.

The male:female ratio in this mostly hospital-based cohort was 1.48 with a male predominance in all age groups. Male predominance was even more pronounced in the age groups >65 years and >75 years.

Most comorbidities did not differ significantly between men and women, while coronary artery disease (18% vs 10%) and smoking rates (14.5 vs 10.5%) were higher in male patients than female patients.

Progression to a critical phase (generally reflecting ICU admission) was seen more often in men than in women (30.6% vs 17.2%). Mean hospital length of stay was longer in male patients (15.4 vs 13.3 days).

Both crude mortality (19.2% vs 12.9%) and COVID-19 attributable mortality (17.1% vs 10.3%) were significantly higher in men.

While most laboratory parameters were comparable between male and female patients with COVID-19, men had significantly higher inflammatory markers (IL-6, CRP, PCT, ferritin) across all phases of disease.

Expert commentary:

Question: What are the clinical implications of your research for men?

Hanses: "Both men (and their treating physicians) should be aware of the fact that men have a worse outcome/higher risk (the main drawback being that we cannot provide a good explanation or different treatment suggestion yet)."

References: Hanses F, et al. Abstract 00363. Men are disproportionally affected by COVID 19: Outcome and degree of inflammation in a large international cohort. ECCVID 2020. 23-25 September 2020.

Follow the latest COVID-19 figures in your region and around the globe with our interactive COVID-19 map.

This article originally appeared on Univadis, part of the Medscape Professional Network.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....